Organization
Stemedica Cell Technologies
2 clinical trials
Clinical trial
A Phase IIa Study of Allogeneic Human Mesenchymal Stem Cells in Subjects With Mild to Moderate Dementia Due to Alzheimer's DiseaseStatus: Recruiting, Estimated PCD: 2024-07-30
Clinical trial
A Phase I/II, Open-Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects for Cutaneous PhotoagingStatus: Active (not recruiting), Estimated PCD: 2024-04-30